NVS vs. PG

In the year-to-date period, NVS achieves a 19.39% return, which is significantly higher than PG's -2.75% return. Over the past 10 years, NVS has underperformed PG with an annualized return of 6.93%, while PG has yielded a comparatively higher 10.38% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Novartis AG (NVS) and The Procter & Gamble Company (PG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current NVS Sharpe Ratio is 1.01, which is higher than the PG Sharpe Ratio of 0.11. The chart below compares the historical Sharpe Ratios of NVS and PG, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

NVS's dividend yield for the trailing twelve months is around 3.56%, more than PG's 2.53% yield.

The maximum NVS drawdown since its inception was -41.72%, smaller than the maximum PG drawdown of -54.23%. Use the drawdown chart below to compare losses from any high point for NVS and PG. For additional features, visit the drawdowns tool.

Novartis AG (NVS) and The Procter & Gamble Company (PG) have volatilities of 9.15% and 9.36%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Novartis AG and The Procter & Gamble Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.